20. 副腎白質ジストロフィー Adrenoleukodystrophy Clinical trials / Disease details


臨床試験数 : 61 薬物数 : 90 - (DrugBank : 31) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 126

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04303416
(ClinicalTrials.gov)
March 9, 20206/3/2020Plasma Exchange With Albumin in AMN PatientsEffect of Plasma Exchange With Albumin in Patients With Adrenomyeloneuropathy: Unicentric, Single Arm, Proof of Concept Study.Adrenomyeloneuropathy;AdrenoleukodystrophyDrug: Albumin solutionOnofre, Aurora Pujol, M.D.NULLCompleted18 Years65 YearsMale5Phase 2/Phase 3Spain
2EUCTR2019-004733-17-ES
(EUCTR)
25/02/202020/12/2019Plasma exchange by albumin replacement in AdrenomyeloneuropathyEffect of plasma exchange by albumin replacement in Adrenomyeloneuropathy: unicentric, single arm, proof of concept trial Adrenomyeloneuropathy
MedDRA version: 20.0;Level: LLT;Classification code 10069075;Term: Adrenomyeloneuropathy without cerebral involvement;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Albunorm® 5%,
Product Name: Albumin
INN or Proposed INN: ALBUMIN
Other descriptive name: ALBUMIN
Aurora Pujol OnofreNULLAuthorised-recruitment may be ongoing or finishedFemale: no
Male: yes
5Phase 2Spain